Return to homepagePandemic Pact

Development of a novel delivery system for mRNA COVID-19 vaccines

  • Funded by Swiss National Science Foundation (SNSF)
  • Total publications:1 publications

Grant number: 52910.1 IP-LS

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2021
    2023

  • Known Financial Commitments (USD)

    $825,923.46

  • Funder

    Swiss National Science Foundation (SNSF)

  • Principal Investigator

    Steve Pascolo

  • Research Location

    Switzerland

  • Lead Research Institution

    N/A

  • Research Priority Alignment

    N/A

  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    Vaccine design and administration

  • Special Interest Tags

    Innovation

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

mRNA vaccines have showcased their tremendous potential amidst the COVID-19 pandemic. In this project, we aim to maximize the potential of mRNA vaccines by developing a novel vaccine carrier system to improve their efficacy, stability, safety, and cost-effectiveness.

Publicationslinked via Europe PMC

Last Updated:an hour ago

View all publications at Europe PMC

Development of Thermostable and Immunogenic Block Copolymer Nanoparticles (BNPs) for mRNA Delivery.